Takuya Osada
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Cancer Research top 1%
- MicroRNA in disease regulation
Papers in
- Immunology 47
- Immunotherapy and Immune Responses 39
- Immune Cell Function and Interaction 14
- T-cell and B-cell Immunology 13
- Co-authors
- H. Kim Lyerly (80 shared papers)Michael A. Morse (63 shared papers)Timothy M. Clay (36 shared papers)Amy Hobeika (41 shared papers)Hirokazu Nagawa (25 shared papers)Nelson H. Tsuno (19 shared papers)Jean‐Bernard Le Pecq (2 shared papers)Alain Delcayre (2 shared papers)
- Journals
- Cancer Research (7 papers)Clinical Cancer Research (7 papers)Cancer Immunology Immunotherapy (6 papers)Journal of Clinical Oncology (6 papers)Journal for ImmunoTherapy of Cancer (5 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Takuya Osada
114 papers receiving 5.6k citations
Takuya Osada's Hit Papers
Peers
Comparison fields: 5 of 124
- Immunology 2.1k
- Cancer Research 1.0k
- Oncology 1.8k
- Molecular Biology 2.6k
- Hepatology 178
Countries citing papers authored by Takuya Osada
This map shows the geographic impact of Takuya Osada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuya Osada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuya Osada more than expected).
Fields of papers citing papers by Takuya Osada
This network shows the impact of papers produced by Takuya Osada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuya Osada. The network helps show where Takuya Osada may publish in the future.
Co-authors
The 25 scholars most cited alongside Takuya Osada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer Hit paper breakdown → | 2005 | 965 |
| 2 | 2008 | 269 | |
| 3 | 2008 | 251 | |
| 4 | 2011 | 226 | |
| 5 | 2000 | 199 | |
| 6 | 2011 | 170 | |
| 7 | 2010 | 158 | |
| 8 | 2011 | 120 | |
| 9 | 2013 | 118 | |
| 10 | 2013 | 117 | |
| 11 | 2000 | 114 | |
| 12 | 2011 | 113 | |
| 13 | 2005 | 106 | |
| 14 | 2010 | 98 | |
| 15 | 2006 | 84 | |
| 16 | 2012 | 84 | |
| 17 | 1996 | 81 | |
| 18 | 2016 | 79 | |
| 19 | 2013 | 73 | |
| 20 | 2015 | 72 |
About Takuya Osada
Takuya Osada is a scholar working on Immunology, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 119 papers that have together received 5.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (39 papers), Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (13 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Cancer Immunotherapy and Biomarkers (11 papers), HER2/EGFR in Cancer Research (9 papers), Virus-based gene therapy research (8 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Immunology (2.1k citations), Cancer Research (1.0k citations), Oncology (1.8k citations), Molecular Biology (2.6k citations) and Hepatology (178 citations). Takuya Osada has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include H. Kim Lyerly, Michael A. Morse, Timothy M. Clay, Amy Hobeika, Hirokazu Nagawa, Nelson H. Tsuno, Jean‐Bernard Le Pecq, Alain Delcayre, Donna Niedzwiecki and Joji Kitayama. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Cancer Immunology Immunotherapy, Journal of Clinical Oncology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.